About Biocon Biocon's Products & Services Research & Development Biocon's Technology Investors Media Careers CSR
Biocon-Media
  > MEDIA
  Overview
  Press Releases
  Media Stories
  Download Center
  Video Gallery
  Photo Gallery
  Media Contacts
  
  Home
  
     
 

Media Stories

2017 2016 2015 2014 2013 2012


  November 2016
04 Nov  EMA accepts Biocon's review plea for drug

  October 2016
29 Oct  Biocon ranked among top 10 global biotech  employers
24 Oct  Biocon is betting big on Biosimilars:  Mazumdar-Shaw
21 Oct  Biosimilars boost Biocon net to Rs 147 cr in  September quarter
05 Oct  Biocon gears up to launch new drugs to  treat diabetes, cancer

  September 2016
02 Sept  Top French Honour for Biocon's Kiran Shaw

  August 2016
01 Aug  'We have enhanced patient access to  insulins across India'

  July 2016
26 Jul  'Latin America, Middle East are key EMs for  our biosimilars'
23 Jul  Biocon April-June net profit up 17% to Rs  147 crore

  June 2016
03 Jun  'Approval in Japan has increased our  confidence'
01 Jun  'We can be very aggressive in US, EU with  biosmilars'

  May 2016
27 May  Biocon gets Karnataka govt nod for Rs  1060-crore plant from price control for  pharma sector

  April 2016
07 Apr  Biocon chief seeks five-year exemption
 from price control for pharma sector

  March 2016
28 Mar  Business Standard:
 Biocon gets nod to sell insulin in Japan
18 Mar  Mint:
 PiSA deal with bolster Biocon's presence in
 global insulin market
15 Mar  Deccan Herald:
 Building the basics

  February 2016
16 Feb  Business Standard:
 Biocon gets nod to sell first generic in EU
08 Feb  Financial Express:
 Biocon set to seek US FDA approval for
 biosimilars

  January 2016
28 Jan  Business Standard:
 Biocon to conduct oral insulin trials
 on its own
23 Jan  Biocon Q3 Net increases 13% at
 Rs 103 crore

 



 

   
 
 
 
 
 
     
  Biocon

Businesses

Recommended sites Biocon on  
  Home
About Us

Investor Relations
Media Relations
Careers
Site Map
Contact Us
Our Growth Accelerators
Fact Sheet
Branded Formulations
Biopharmaceuticals
Research Services
Active Discovery Program

ABLE
Karnataka Vision Group on BT
Syngene International
Biocon Academy

    Linked In   
       
  Report adverse event/side effects and product complaints    
       
  * Disclaimer            © 2016, Biocon. All Rights Reserved